Despite advances in modern medicine, cancer remains all too common and deadly. At its core, cancer is a disease of our DNA. As such, many cancers are passed from parents to children, making cancer one of the most commonly inherited diseases. Presently, we have no meaningful methods of “preventing” the malignant transformation that occurs as a result of an inherited gene, but investigators have identified several genetic mutations and subsequently developed risk-reduction strategies that sometimes involve surgery.
Get full access to this article
View all access options for this article.
References
1.
CullerD., GrimesS.J., AchesonL.S.Cancer genetics in primary care.Prim Care2004; 31: 649–83, xi.
2.
American Cancer Society.Cancer facts and figures 2006.Atlanta, GA: American Cancer Society, 2006, pp 1–58.
3.
PharoahP.D., LipscombeJ.M., RedmanK.L.Familial predisposition to breast cancer in a British population: implications for prevention.Eur J Cancer2000; 36: 773–9.
4.
American Cancer Society.2008.
5.
VasenH.F., MosleinG., AlonsoA.Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).J Med Genet2007; 44: 353–62.
6.
VasenH.F., MosleinG., AlonsoA.Guidelines for the clinical management of familial adenomatous polyposis (FAP).Gut2008; 57: 704–13.
7.
AretzS., UhlhaasS., CaspariR.Frequency and parental origin of de novo APC mutations in familial adenomatous polyposis.Eur J Hum Genet2004; 12: 52–8.
8.
NielsenM., HesF.J., NagengastF.M.Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.Clin Genet2007; 71: 427–33.
9.
GiardielloF.M., BrensingerJ.D., PetersenG.M.The use and interpretation of commercial APC gene testing for familial adenomatous polyposis.N Engl J Med1997; 336: 823–7.
10.
ChurchJ., SimmangC.Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer).Dis Colon Rectum2003; 46: 1001–12.
RemziF.H., ChurchJ.M., BastJ.Mucosectomy vs. stapled ileal pouch-anal anastomosis in patients with familial adenomatous polyposis: functional outcome and neoplasia control.Dis Colon Rectum2001; 44: 1590–6.
13.
ParcY.R., OlschwangS., DesaintB.Familial adenomatous polyposis: prevalence of adenomas in the ileal pouch after restorative proctocolectomy.Ann Surg2001; 233: 360–4.
14.
BertarioL., PresciuttiniS., SalaP.Causes of death and postsurgical survival in familial adenomatous polyposis: results from the Italian Registry. Italian Registry of Familial Polyposis Writing Committee.Semin Surg Oncol1994; 10: 225–34.
15.
HeiskanenI., LuostarinenT., JarvinenH.J.Impact of screening examinations on survival in familial adenomatous polyposis.Scand J Gastroenterol2000; 35: 1284–7.
16.
GrovesC.J., SaundersB.P., SpigelmanA.D.Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study.Gut2002; 50: 636–41.
17.
BrosensL.A., KellerJ.J., OfferhausG.J.Prevention and management of duodenal polyps in familial adenomatous polyposis.Gut2005; 54: 1034–43.
18.
LynchH.T., de la ChapelleA.Hereditary colorectal cancer.N Engl J Med2003; 348: 919–32.
19.
DunlopM.G., FarringtonS.M., CarothersA.D.Cancer risk associated with germline DNA mismatch repair gene mutations.Hum Mol Genet1997; 6: 105–10.
FitzgibbonsR.J.Jr., LynchH.T., StanislavG.V.Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II).Ann Surg1987; 206: 289–95.
22.
PeltomakiP., VasenH.Mutations associated with HNPCC predisposition–Update of ICG-HNPCC/INSiGHT mutation database.Dis Markers2004; 20: 269–76.
23.
AarnioM., MecklinJ.P., AaltonenL.A.Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome.Int J Cancer1995; 64: 430–3.
24.
LindorN.M., PetersenG.M., HadleyD.W.Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.JAMA2006; 296: 1507–17.
25.
DesaiT.K., BarkelD.Syndromic colon cancer: lynch syndrome and familial adenomatous polyposis.Gastroenterol Clin North Am2008; 37: 47–72, vi.
26.
SyngalS., BandipalliamP., BolandC.R.Surveillance of patients at high risk for colorectal cancer.Med Clin North Am2005; 89: 61–84.
27.
BurkeW., PetersenG., LynchP.Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium.JAMA1997; 277: 915–9.
28.
SchmelerK.M., LynchH.T., ChenL.M.Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.N Engl J Med2006; 354: 261–9.
29.
LeeJ.S., PetrelliN.J., Rodriguez-BigasM.A.Rectal cancer in hereditary nonpolyposis colorectal cancer.Am J Surg2001; 181: 207–10.
30.
Rodriguez-BigasM.A., VasenH.F., Pekka-MecklinJ.Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC.Ann Surg1997; 225: 202–7.
31.
WaneboH.J., KennedyB.J., ChmielJ.Cancer of the stomach. A patient care study by the American College of Surgeons.Ann Surg1993; 218: 583–92.
32.
KaurahP., MacMillanA., BoydN.Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.JAMA2007; 297: 2360–72.
33.
PharoahP.D., GuilfordP., CaldasC.Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families.Gastroenterology2001; 121: 1348–53.
34.
CaldasC., HahnS.A., da CostaL.T.Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma.Nat Genet1994; 8: 27–32.
HuntsmanD.G., CarneiroF., LewisF.R.Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.N Engl J Med2001; 344: 1904–9.
37.
ShawD., BlairV., FrampA.Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy?Gut2005; 54: 461–8.
38.
PedrazzaniC., CorsoG., MarrelliD.E-cadherin and hereditary diffuse gastric cancer.Surgery2007; 142: 645–57.
39.
UmarA., BolandC.R., TerdimanJ.P.Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.J Natl Cancer Inst2004; 96: 261–8.
40.
RobsonM., OffitK.Clinical practice. Management of an inherited predisposition to breast cancer.N Engl J Med2007; 357: 154–62.
41.
CaldasC., CarneiroF., LynchH.T.Familial gastric cancer: Overview and guidelines for management.J Med Genet1999; 36: 873–80.
